+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Global Eye Health Supplements Market By Formulation, By Indication, By Ingredient Type, By Region, Industry Analysis and Forecast, 2020 - 2026

  • ID: 5241442
  • Report
  • January 2021
  • Region: Global
  • 245 pages
  • Marqual IT Solutions Pvt. Ltd (KBV Research)

FEATURED COMPANIES

  • EyeScience Labs, LLC
  • Kemin Industries, Inc.
  • Novartis AG
  • NutraChamps, Inc.
  • Nutrivein
  • Pfizer, Inc.
The Global Eye Health Supplements Market size is expected to reach $2.4 billion by 2026, rising at a market growth of 10% CAGR during the forecast period. Eye supplements are dietary and nutritional products that are helpful in maintaining eye health and good vision. The eye health supplements contain vitamin A, omega-3 fatty acids, lutein and zeaxanthin, gamma-linolenic acid, etc.

These nutritional supplements are beneficial in sustaining eye function, decrease the cases of age-related eye diseases, and also protect eyes from harmful radiations. The growth of the eye health supplements market is mainly accredited to the increasing occurrence of eye diseases and the growing geriatric population. Furthermore, rising industrial developments are further anticipated to drive market growth in the coming years. Though, the cost of eye health supplements is high and product availability is also lacking, these factors are hampering the market growth.

The increasing cases of vision impairment and rising myopic population, mainly during the COVID-19 pandemic, due to the increasing use of screens and attending virtual meetings while working from home, is one of the major factors boosting the market. Rising cases of myopia are due to increased risk of several progressive eye disorders including glaucoma, cataract, and age-related macular degeneration. Increasing inclination for eye health supplements among the geriatric population and millennials, highly vulnerable to digital eye fatigue and it is further driving the market globally. The rise in prevalence of numerous eye conditions including dry eye syndrome, cataract, Age-related Macular Degeneration (AMD), and inflammation coupled with the increasing recommendation for eye health supplements by ophthalmologists for treatment and prevention of these disorders is further boosting the market.



By Formulation

Based on Formulation, the market is segmented into Tablets, Capsules, Powder, Softgels, and Liquid. The soft gels segment is likely to show a considerable growth rate over the forecasted period. It is an effective form of delivering liquid or oil-based supplements. Researchers believe that those supplements which are delivered in their native form are much more effective than modified forms. Moreover, nutrients like krill oil and fish oil are mostly encapsulated in soft gels in order to suppress negative effects that can change the taste and aroma of the oils.



By Indication

Based on Indication, the market is segmented into Age-related Macular Degeneration (AMD), Dry Eye Syndrome, Inflammation, Cataract and Others. In 2019, the AMD segment accounted for the largest share of the market. An increasing prevalence of AMD across the world is further contributing to segment growth. The dry eye syndrome segment is anticipated to show a significant growth rate over the forecast period.

By Ingredient Type

Based on Ingredient Type, the market is segmented into Lutein and Zeaxanthin, Antioxidants, Flavonoids, Alpha-Lipoic Acid, Omega-3 Fatty acids, Coenzyme Q10, Astaxanthin and Others. Lutein and Zeaxanthin ingredients for eye health supplements garnered the largest revenue share in 2019. This is attributed to growing awareness about the benefits provided by Zeaxanthin and Lutein supplements used for the prevention and treatment of various eye disorders such as diabetic retinopathy, AMD, uveitis, and cataract. Furthermore, the increasing occurrence of eye disorders, mainly AMD, and increasing recommendations for these eye-health supplements by clinicians, ophthalmologists, and vision scientists are also contributing to the growth of the segment.

By Region

Based on Regions, the market is segmented into North America, Europe, Asia Pacific, and Latin America, Middle East & Africa. The market for eye health supplements in the Asia Pacific is expected to show a considerable growth rate in the coming years. The existence of a large number of local market players are offering affordable and innovative eye health supplements, and contract manufacturing hubs for eye health supplements are continuously increasing in China, India, and the Philippines, thereby driving the market growth in the region.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include The Nature’s Bounty Co. (The Carlyle Group L.P.), Pfizer, Inc., Alticor Inc. (Amway Corporation), Novartis AG, Kemin Industries, Inc., ZeaVision LLC (EyePromise), EyeScience Labs, LLC, Vitabiotics Ltd., Nutrivein and NutraChamps, Inc.

Strategies deployed in Eye Health Supplements Market

Oct-2019: Novartis received FDA approval for Beovu (brolucizumab) injection, also known as RTH258. This injection is used for the treatment of wet age-related macular degeneration (AMD).

May-2019: Amway expanded its kid’s nutrition portfolio with the introduction of Nutrilite DHA Yummies. The Nutrilite DHA Yummies Soft Gel maintains the healthy nutritional intake of the children as it provides the DHA.

May-2019: EyePromise introduced Screen Shield Teen to its premium EyePromise eye vitamin line. Screen Shield Teen contain naturally-flavored fruit punch chewable eye vitamin. It is developed with all-natural zeaxanthin and other nutrients to prevent children’s eyes from the ill effects of increasing screen exposure.

May-2019: Novartis signed an agreement with Takeda Pharmaceutical Company Limited to acquire the assets associated with Xiidra (lifitegrast ophthalmic solution) 5% worldwide. Xiidra is the first and only prescription treatment that treats both signs and symptoms of dry eye by inhibiting inflammation caused by the disease.

Dec-2018: Pfizer signed an agreement with GlaxoSmithKline, a British multinational pharmaceutical company. In this agreement, they created a premier global consumer healthcare company, GSK Consumer Healthcare. The combined brand portfolio formed the world's largest OTC business with leadership positions in respiratory and vitamins, pain relief, minerals and supplements, and therapeutic oral health.

Jun-2018: EyePromise launched a new and improved formula to its EyePromise Restore line, with the addition of vitamins B6 and B12, folic acid, and Coenzyme Q10. Eyepromise Restore is an ocular nutrition supplement designed to protect and support vision for individuals concerned with, at-risk for, or in the early stages of age-related macular degeneration.

Jul-2017: Kemin Industries got the approval for Kemin ZeaONE Zeaxanthin by the National Health and Family Planning Commission (NHFPC) of China. Kemin ZeaONE Zeaxanthin is a naturally-sourced zeaxanthin produces FloraGLO Lutein, the most studied lutein brand in the world and the number one lutein recommended by doctors in the U.S.

May-2017: Alcon, a division of Novartis, introduced a chewable vitamin for supporting eye health in people with age-related macular degeneration. The Systane ICaps vitamins contain the following per serving: 500 mg of vitamin C, 400 IU of vitamin E, 25 mg of zinc, 2 mg of copper, 10 mg of lutein and 2 mg of zeaxanthin.

Jul-2016: Kemin Industries received patent by the United States Patent and Trademark Office for the role of its products, FloraGLO Lutein and ZeaONE Zeaxanthin. Kemin’s patent permits vitamin and dietary supplement manufacturers uses FloraGLO and/or ZeaONE to position their products for blue light protection. The patent specifically included products involving ocular antioxidants like lutein and zeaxanthin employed to protect the eye from light-induced damage.

Scope of the Study

Market Segments covered in the Report:

By Formulation
  • Tablets
  • Capsules
  • Powder
  • Softgels,
  • Liquid
By Indication
  • Age-related Macular Degeneration (AMD)
  • Dry Eye Syndrome
  • Inflammation
  • Cataract
  • Others
By Ingredient Type
  • Lutein and Zeaxanthin
  • Antioxidants
  • Flavonoids
  • Alpha-Lipoic Acid
  • Omega-3 Fatty acids
  • Coenzyme Q10
  • Astaxanthin
  • Others
By Geography
  • North America
  • US
  • Canada
  • Mexico
  • Rest of North America
  • Europe
  • Germany
  • UK
  • France
  • Russia
  • Spain
  • Italy
  • Rest of Europe
  • Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Singapore
  • Malaysia
  • Rest of Asia Pacific
  • LAMEA
  • Brazil
  • Argentina
  • UAE
  • Saudi Arabia
  • South Africa
  • Nigeria
  • Rest of LAMEA
Companies Profiled
  • The Nature’s Bounty Co. (The Carlyle Group L.P.)
  • Pfizer, Inc.
  • Alticor Inc. (Amway Corporation)
  • Novartis AG
  • Kemin Industries, Inc.
  • ZeaVision LLC (EyePromise)
  • EyeScience Labs, LLC
  • Vitabiotics Ltd.
  • Nutrivein
  • NutraChamps, Inc.
Unique Offerings from the Publisher
  • Exhaustive coverage
  • Highest number of market tables and figures
  • Subscription based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • EyeScience Labs, LLC
  • Kemin Industries, Inc.
  • Novartis AG
  • NutraChamps, Inc.
  • Nutrivein
  • Pfizer, Inc.
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Global Eye Health Supplements Market, by Formulation
1.4.2 Global Eye Health Supplements Market, by Indication
1.4.3 Global Eye Health Supplements Market, by Ingredient Type
1.4.4 Global Eye Health Supplements Market, by Geography
1.5 Methodology for the research

Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.2 Market composition and scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints

Chapter 3. Strategies deployed in Eye Health Supplements Market

Chapter 4. Global Eye Health Supplements Market by Formulation
4.1 Global Tablets Market by Region
4.2 Global Capsules Market by Region
4.3 Global Powder Market by Region
4.4 Global Softgels Market by Region
4.5 Global Others Market by Region

Chapter 5. Global Eye Health Supplements Market by Indication
5.1 Global Age-related Macular Degeneration (AMD) Market by Region
5.2 Global Dry Eye Syndrome Market by Region
5.3 Global Inflammation Market by Region
5.4 Global Cataract Market by Region
5.5 Global Other Indication Market by Region

Chapter 6. Global Eye Health Supplements Market by Ingredient Type
6.1 Global Lutein and Zeaxanthin Market by Region
6.2 Global Antioxidants Market by Region
6.3 Global Flavonoids Market by Region
6.4 Global Alpha-Lipoic Acid Market by Region
6.5 Global Omega-3 Fatty acids Market by Region
6.6 Global Coenzyme Q10 Market by Region
6.7 Global Astaxanthin Market by Region
6.8 Global Others Market by Region

Chapter 7. Global Eye Health Supplements Market by Region
7.1 North America Eye Health Supplements Market
7.1.1 North America Eye Health Supplements Market by Formulation
7.1.1.1 North America Tablets Market by Country
7.1.1.2 North America Capsules Market by Country
7.1.1.3 North America Powder Market by Country
7.1.1.4 North America Softgels Market by Country
7.1.1.5 North America Others Market by Country
7.1.2 North America Eye Health Supplements Market by Indication
7.1.2.1 North America Age-related Macular Degeneration (AMD) Market by Country
7.1.2.2 North America Dry Eye Syndrome Market by Country
7.1.2.3 North America Inflammation Market by Country
7.1.2.4 North America Cataract Market by Country
7.1.2.5 North America Other Indication Market by Country
7.1.3 North America Eye Health Supplements Market by Ingredient Type
7.1.3.1 North America Lutein and Zeaxanthin Market by Country
7.1.3.2 North America Antioxidants Market by Country
7.1.3.3 North America Flavonoids Market by Country
7.1.3.4 North America Alpha-Lipoic Acid Market by Country
7.1.3.5 North America Omega-3 Fatty acids Market by Country
7.1.3.6 North America Coenzyme Q10 Market by Country
7.1.3.7 North America Astaxanthin Market by Country
7.1.3.8 North America Others Market by Country
7.1.4 North America Eye Health Supplements Market by Country
7.1.4.1 US Eye Health Supplements Market
7.1.4.1.1 US Eye Health Supplements Market by Formulation
7.1.4.1.2 US Eye Health Supplements Market by Indication
7.1.4.1.3 US Eye Health Supplements Market by Ingredient Type
7.1.4.2 Canada Eye Health Supplements Market
7.1.4.2.1 Canada Eye Health Supplements Market by Formulation
7.1.4.2.2 Canada Eye Health Supplements Market by Indication
7.1.4.2.3 Canada Eye Health Supplements Market by Ingredient Type
7.1.4.3 Mexico Eye Health Supplements Market
7.1.4.3.1 Mexico Eye Health Supplements Market by Formulation
7.1.4.3.2 Mexico Eye Health Supplements Market by Indication
7.1.4.3.3 Mexico Eye Health Supplements Market by Ingredient Type
7.1.4.4 Rest of North America Eye Health Supplements Market
7.1.4.4.1 Rest of North America Eye Health Supplements Market by Formulation
7.1.4.4.2 Rest of North America Eye Health Supplements Market by Indication
7.1.4.4.3 Rest of North America Eye Health Supplements Market by Ingredient Type
7.2 Europe Eye Health Supplements Market
7.2.1 Europe Eye Health Supplements Market by Formulation
7.2.1.1 Europe Tablets Market by Country
7.2.1.2 Europe Capsules Market by Country
7.2.1.3 Europe Powder Market by Country
7.2.1.4 Europe Softgels Market by Country
7.2.1.5 Europe Liquid Market by Country
7.2.2 Europe Eye Health Supplements Market by Indication
7.2.2.1 Europe Age-related Macular Degeneration (AMD) Market by Country
7.2.2.2 Europe Dry Eye Syndrome Market by Country
7.2.2.3 Europe Inflammation Market by Country
7.2.2.4 Europe Cataract Market by Country
7.2.2.5 Europe Other Indication Market by Country
7.2.3 Europe Eye Health Supplements Market by Ingredient Type
7.2.3.1 Europe Lutein and Zeaxanthin Market by Country
7.2.3.2 Europe Antioxidants Market by Country
7.2.3.3 Europe Flavonoids Market by Country
7.2.3.4 Europe Alpha-Lipoic Acid Market by Country
7.2.3.5 Europe Omega-3 Fatty acids Market by Country
7.2.3.6 Europe Coenzyme Q10 Market by Country
7.2.3.7 Europe Astaxanthin Market by Country
7.2.3.8 Europe Others Market by Country
7.2.4 Europe Eye Health Supplements Market by Country
7.2.4.1 Germany Eye Health Supplements Market
7.2.4.1.1 Germany Eye Health Supplements Market by Formulation
7.2.4.1.2 Germany Eye Health Supplements Market by Indication
7.2.4.1.3 Germany Eye Health Supplements Market by Ingredient Type
7.2.4.2 UK Eye Health Supplements Market
7.2.4.2.1 UK Eye Health Supplements Market by Formulation
7.2.4.2.2 UK Eye Health Supplements Market by Indication
7.2.4.2.3 UK Eye Health Supplements Market by Ingredient Type
7.2.4.3 France Eye Health Supplements Market
7.2.4.3.1 France Eye Health Supplements Market by Formulation
7.2.4.3.2 France Eye Health Supplements Market by Indication
7.2.4.3.3 France Eye Health Supplements Market by Ingredient Type
7.2.4.4 Russia Eye Health Supplements Market
7.2.4.4.1 Russia Eye Health Supplements Market by Formulation
7.2.4.4.2 Russia Eye Health Supplements Market by Indication
7.2.4.4.3 Russia Eye Health Supplements Market by Ingredient Type
7.2.4.5 Spain Eye Health Supplements Market
7.2.4.5.1 Spain Eye Health Supplements Market by Formulation
7.2.4.5.2 Spain Eye Health Supplements Market by Indication
7.2.4.5.3 Spain Eye Health Supplements Market by Ingredient Type
7.2.4.6 Italy Eye Health Supplements Market
7.2.4.6.1 Italy Eye Health Supplements Market by Formulation
7.2.4.6.2 Italy Eye Health Supplements Market by Indication
7.2.4.6.3 Italy Eye Health Supplements Market by Ingredient Type
7.2.4.7 Rest of Europe Eye Health Supplements Market
7.2.4.7.1 Rest of Europe Eye Health Supplements Market by Formulation
7.2.4.7.2 Rest of Europe Eye Health Supplements Market by Indication
7.2.4.7.3 Rest of Europe Eye Health Supplements Market by Ingredient Type
7.3 Asia Pacific Eye Health Supplements Market
7.3.1 Asia Pacific Eye Health Supplements Market by Formulation
7.3.1.1 Asia Pacific Tablets Market by Country
7.3.1.2 Asia Pacific Capsules Market by Country
7.3.1.3 Asia Pacific Powder Market by Country
7.3.1.4 Asia Pacific Softgels Market by Country
7.3.1.5 Asia Pacific Liquid Market by Country
7.3.2 Asia Pacific Eye Health Supplements Market by Indication
7.3.2.1 Asia Pacific Age-related Macular Degeneration (AMD) Market by Country
7.3.2.2 Asia Pacific Dry Eye Syndrome Market by Country
7.3.2.3 Asia Pacific Inflammation Market by Country
7.3.2.4 Asia Pacific Cataract Market by Country
7.3.2.5 Asia Pacific Other Indication Market by Country
7.3.3 Asia Pacific Eye Health Supplements Market by Ingredient Type
7.3.3.1 Asia Pacific Lutein and Zeaxanthin Market by Country
7.3.3.2 Asia Pacific Antioxidants Market by Country
7.3.3.3 Asia Pacific Flavonoids Market by Country
7.3.3.4 Asia Pacific Alpha-Lipoic Acid Market by Country
7.3.3.5 Asia Pacific Omega-3 Fatty acids Market by Country
7.3.3.6 Asia Pacific Coenzyme Q10 Market by Country
7.3.3.7 Asia Pacific Astaxanthin Market by Country
7.3.3.8 Asia Pacific Others Market by Country
7.3.4 Asia Pacific Eye Health Supplements Market by Country
7.3.4.1 China Eye Health Supplements Market
7.3.4.1.1 China Eye Health Supplements Market by Formulation
7.3.4.1.2 China Eye Health Supplements Market by Indication
7.3.4.1.3 China Eye Health Supplements Market by Ingredient Type
7.3.4.2 Japan Eye Health Supplements Market
7.3.4.2.1 Japan Eye Health Supplements Market by Formulation
7.3.4.2.2 Japan Eye Health Supplements Market by Indication
7.3.4.2.3 Japan Eye Health Supplements Market by Ingredient Type
7.3.4.3 India Eye Health Supplements Market
7.3.4.3.1 India Eye Health Supplements Market by Formulation
7.3.4.3.2 India Eye Health Supplements Market by Indication
7.3.4.3.3 India Eye Health Supplements Market by Ingredient Type
7.3.4.4 South Korea Eye Health Supplements Market
7.3.4.4.1 South Korea Eye Health Supplements Market by Formulation
7.3.4.4.2 South Korea Eye Health Supplements Market by Indication
7.3.4.4.3 South Korea Eye Health Supplements Market by Ingredient Type
7.3.4.5 Singapore Eye Health Supplements Market
7.3.4.5.1 Singapore Eye Health Supplements Market by Formulation
7.3.4.5.2 Singapore Eye Health Supplements Market by Indication
7.3.4.5.3 Singapore Eye Health Supplements Market by Ingredient Type
7.3.4.6 Malaysia Eye Health Supplements Market
7.3.4.6.1 Malaysia Eye Health Supplements Market by Formulation
7.3.4.6.2 Malaysia Eye Health Supplements Market by Indication
7.3.4.6.3 Malaysia Eye Health Supplements Market by Ingredient Type
7.3.4.7 Rest of Asia Pacific Eye Health Supplements Market
7.3.4.7.1 Rest of Asia Pacific Eye Health Supplements Market by Formulation
7.3.4.7.2 Rest of Asia Pacific Eye Health Supplements Market by Indication
7.3.4.7.3 Rest of Asia Pacific Eye Health Supplements Market by Ingredient Type
7.4 LAMEA Eye Health Supplements Market
7.4.1 LAMEA Eye Health Supplements Market by Formulation
7.4.1.1 LAMEA Tablets Market by Country
7.4.1.2 LAMEA Capsules Market by Country
7.4.1.3 LAMEA Powder Market by Country
7.4.1.4 LAMEA Softgels Market by Country
7.4.1.5 LAMEA Liquid Market by Country
7.4.2 LAMEA Eye Health Supplements Market by Indication
7.4.2.1 LAMEA Age-related Macular Degeneration (AMD) Market by Country
7.4.2.2 LAMEA Dry Eye Syndrome Market by Country
7.4.2.3 LAMEA Inflammation Market by Country
7.4.2.4 LAMEA Cataract Market by Country
7.4.2.5 LAMEA Other Indication Market by Country
7.4.3 LAMEA Eye Health Supplements Market by Ingredient Type
7.4.3.1 LAMEA Lutein and Zeaxanthin Market by Country
7.4.3.2 LAMEA Antioxidants Market by Country
7.4.3.3 LAMEA Flavonoids Market by Country
7.4.3.4 LAMEA Alpha-Lipoic Acid Market by Country
7.4.3.5 LAMEA Omega-3 Fatty acids Market by Country
7.4.3.6 LAMEA Coenzyme Q10 Market by Country
7.4.3.7 LAMEA Astaxanthin Market by Country
7.4.3.8 LAMEA Others Market by Country
7.4.4 LAMEA Eye Health Supplements Market by Country
7.4.4.1 Brazil Eye Health Supplements Market
7.4.4.1.1 Brazil Eye Health Supplements Market by Formulation
7.4.4.1.2 Brazil Eye Health Supplements Market by Indication
7.4.4.1.3 Brazil Eye Health Supplements Market by Ingredient Type
7.4.4.2 Argentina Eye Health Supplements Market
7.4.4.2.1 Argentina Eye Health Supplements Market by Formulation
7.4.4.2.2 Argentina Eye Health Supplements Market by Indication
7.4.4.2.3 Argentina Eye Health Supplements Market by Ingredient Type
7.4.4.3 UAE Eye Health Supplements Market
7.4.4.3.1 UAE Eye Health Supplements Market by Formulation
7.4.4.3.2 UAE Eye Health Supplements Market by Indication
7.4.4.3.3 UAE Eye Health Supplements Market by Ingredient Type
7.4.4.4 Saudi Arabia Eye Health Supplements Market
7.4.4.4.1 Saudi Arabia Eye Health Supplements Market by Formulation
7.4.4.4.2 Saudi Arabia Eye Health Supplements Market by Indication
7.4.4.4.3 Saudi Arabia Eye Health Supplements Market by Ingredient Type
7.4.4.5 South Africa Eye Health Supplements Market
7.4.4.5.1 South Africa Eye Health Supplements Market by Formulation
7.4.4.5.2 South Africa Eye Health Supplements Market by Indication
7.4.4.5.3 South Africa Eye Health Supplements Market by Ingredient Type
7.4.4.6 Nigeria Eye Health Supplements Market
7.4.4.6.1 Nigeria Eye Health Supplements Market by Formulation
7.4.4.6.2 Nigeria Eye Health Supplements Market by Indication
7.4.4.6.3 Nigeria Eye Health Supplements Market by Ingredient Type
7.4.4.7 Rest of LAMEA Eye Health Supplements Market
7.4.4.7.1 Rest of LAMEA Eye Health Supplements Market by Formulation
7.4.4.7.2 Rest of LAMEA Eye Health Supplements Market by Indication
7.4.4.7.3 Rest of LAMEA Eye Health Supplements Market by Ingredient Type

Chapter 8. Company Profiles
8.1 The Nature’s Bounty Co. (The Carlyle Group L.P.)
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Segmental and Regional Analysis
8.2 Pfizer, Inc.
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Segmental and Regional Analysis
8.2.4 Recent strategies and developments:
8.2.4.1 Partnerships, Collaborations, and Agreements:
8.3 Alticor Inc. (Amway Corporation)
8.3.1 Company Overview
8.3.2 Recent strategies and developments:
8.3.2.1 Product Launches and Product Expansions:
8.4 Novartis AG
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Segmental and Regional Analysis
8.4.4 Recent strategies and developments:
8.4.4.1 Acquisition and Mergers:
8.4.4.2 Product Launches and Product Expansions:
8.4.4.3 Approvals:
8.5 Kemin Industries, Inc.
8.5.1 Company Overview
8.5.2 Recent strategies and developments:
8.5.2.1 Approvals:
8.6 ZeaVision LLC (EyePromise)
8.6.1 Company Overview
8.6.2 Recent strategies and developments:
8.6.2.1 Product Launches and Product Expansions:
8.7 EyeScience Labs, LLC
8.7.1 Company Overview
8.8 Vitabiotics Ltd.
8.8.1 Company Overview
8.9 Nutrivein
8.9.1 Company Overview
8.10. NutraChamps, Inc.
8.10.1 Company Overview
Note: Product cover images may vary from those shown
  • The Nature’s Bounty Co. (The Carlyle Group L.P.)
  • Pfizer, Inc.
  • Alticor Inc. (Amway Corporation)
  • Novartis AG
  • Kemin Industries, Inc.
  • ZeaVision LLC (EyePromise)
  • EyeScience Labs, LLC
  • Vitabiotics Ltd.
  • Nutrivein
  • NutraChamps, Inc.
Note: Product cover images may vary from those shown

Loading
LOADING...

Adroll
adroll